Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma

Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma

Richard H Stanford,1 Manan Shah,2 Anna O D&#39;Souza21GlaxoSmithKline, Research Triangle Park, Durham, NC, 2Xcenda, Palm Harbor, FL, USABackground: The purpose of this study (GSK ADA111194) was to compare asthma-related health care utilization and costs associated with fluticasone propionate...

Full description

Bibliographic Details
Main Authors:	Stanford RH, Shah M, D&#39;Souza AO
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-12-01
Series:	Journal of Asthma and Allergy
Online Access:	http://www.dovepress.com/fluticasone-propionate-salmeterol-versus-inhaled-corticosteroids-plus--a11825

Similar Items

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
by: Pavord, I, et al.
Published: (2007)

Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population
by: Dalal AA, et al.
Published: (2012-01-01)

An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis
by: Zhengbo Wei, et al.
Published: (2023-12-01)

Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Hilla Mills, et al.
Published: (2022-01-01)

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
by: Barnes, N, et al.
Published: (2006)

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
by: Barbara P Yawn, et al.
Published: (2010-06-01)

Managing moderate-to-severe paediatric asthma: a scoping review of the efficacy and safety of fluticasone propionate/salmeterol
by: Sira Nanthapisal, et al.
Published: (2023-07-01)

Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Emergency Medicine International
Published: (2024-01-01)

Salmeterol/fluticasone propionate (50/250 µg) combination is superior to double dose fluticasone (500 µg) for the treatment of symptomatic moderate asthma
by: K-C Bergmann, et al.
Published: (2004-01-01)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta Alessandra, et al.
Published: (2012-07-01)

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
by: Nina Maria Ainali, et al.
Published: (2020-08-01)

New developed spectrophotometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in bulk powder and Seritide® diskus inhalation
by: Ahmed Samir, et al.
Published: (2012-12-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

A Retrospective Study Evaluating Asthma Control in Patients on Fluticasone Propionate/Salmeterol Proactive Regular Dosing with a History of Uncontrolled Asthma
by: Ahmad Izuanuddin Ismail, et al.
Published: (2024-11-01)

Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
by: Kenneth R Chapman, et al.
Published: (1999-01-01)

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device
by: Donald P. Tashkin, et al.
Published: (2021-01-01)

Non-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2010-12-01)

Montelukast as Add-On Therapy to Inhaled Corticosteroids in the Management of Asthma (The SAS Trial)
by: J Mark FitzGerald, et al.
Published: (2009-01-01)

Effect of Fluticasone 250 μg/salmeterol 50 μg and Montelukast on Exhaled Nitric Oxide in Asthmatic Patients
by: Arthur F Gelb, et al.
Published: (2008-01-01)

Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study
by: Henrik Watz, et al.
Published: (2020-04-01)

The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD
by: Henrik Watz, et al.
Published: (2020-12-01)

Comparison of Oral Montelukast and Intranasal Fluticasone in Patients with Asthma and Allergic Rhinitis
by: Apar Jindal, et al.
Published: (2016-08-01)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)

Inhaled Beclomethasone with or whiteout Montelukast in the Management of Pediatric Persistent Asthma
by: I Mohammadzadeh, et al.
Published: (2018-07-01)

Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
by: Bhanu Prakash Kolasani, et al.
Published: (2013-09-01)

Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine
by: Mohammad H. Alyami, et al.
Published: (2022-03-01)

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy
by: Moretz C, et al.
Published: (2020-10-01)

Montelukaste = Fluticasona + Salmeterol para asma persistente moderada?
by: Benedetta Disaró
Published: (2007-09-01)

Inhaled fluticasone propionate impairs pulmonary clearance of <it>Klebsiella Pneumoniae</it> in mice
by: Patterson Craig M, et al.
Published: (2012-05-01)

Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol
by: Nulma S. Jentzsch, et al.
Published: (2019-01-01)

Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD
by: Gao J, et al.
Published: (2015-04-01)

Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol
by: Nulma S. Jentzsch, et al.
Published: (2019-01-01)

The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler<sup>®</sup> in COPD Patients in the Daily Clinical Practice
by: Zbigniew Doniec, et al.
Published: (2022-11-01)

Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice
by: Ledford Dennis, et al.
Published: (2006-05-01)

Effectiveness of Indacaterol-Glycopyrronium in preventing COPD exacerbations in comparison to Salmeterol-Fluticasone
by: Shamim Ahmed, et al.
Published: (2022-02-01)

Development of Novel Fluticasone/Salmeterol/Tiotropium-Loaded Dry Powder Inhaler and Bioequivalence Assessment to Commercial Products in Rats
by: Hyukjun Cho, et al.
Published: (2025-01-01)

Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease
by: Asai K, et al.
Published: (2015-04-01)

Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial
by: Anna Płoszczuk, et al.
Published: (2018-05-01)

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma
by: van Zyl-Smit RN, et al.
Published: (2023-01-01)

Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)
by: Paul K Keith, et al.
Published: (2009-01-01)